Obesity, Obesity, Visceral, Overweight and Obesity, Body Fat Disorder, Feeding and Eating Disorders, Hormone Disturbance, Weight Loss
Conditions
Keywords
obesity, overweight, fat percentage, body fat, enteral feeding, fat loss
Brief summary
Medical Supervised Duodenal-Enteral Feeding for Overweight, Obesity and Increased Body Fat Percentage Treatment based on an intervention procedure performed by a Licensed Nutritionist Doctor for weight loss and loss of fat percentage in patients who need it.
Detailed description
Medical Supervised Duodenal-Enteral Feeding for Overweight, Obesity and Increased Body Fat Percentage Treatment based on an intervention procedure performed by a Licensed Nutritionist Doctor for weight loss and loss of fat percentage in patients who need it. The feeding is by nasogastric-duodenal tube depending on the desired fat loss and / or weight in relation to the basal metabolism. Feeding by tube of 12-29 days, continuing with personalized nutritional treatment for 2 weeks and physical activity during the protocol. Losses of weight and / or expected fat greater than 10%. The results will be compared with bariatric surgery. The main objective is to provide a tool for the obesity epidemic that can be applied worldwide by doctors without the complications of surgery and with a lower price for health systems and controlling the actions of the hormones leptin and ghrelin.
Interventions
DIETARY_SUPPLEMENTNasogastroduodenal Protocol
Complete nutrition (carbohydrates, lipids, proteins, vitamins, oligoelements)
OTHERControl
Progress registration of body composition values
OTHERData analysis
Statistical analysis of all data
Sponsors
University of Alicante
Universidad Miguel Hernandez de Elche
BiomediKcal
Study design
Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE
Intervention model description
Duodenal-Enteral medical supervised feeding response
Eligibility
Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes
Inclusion criteria
\- Desire for weight loss, desire to improve body image, voluntariness
Exclusion criteria
\- esophageal alteration or swallowing, not sign the informed consent, acute active disease
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Weightloss | Change from Baseline weight at 1 and 3 months | Decrease, minor difference in weight at the end of treatment |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Fat loss | Change from Baseline fat percentage at 1 and 3 months | Decrease, minor difference in percentage of fat at the end of treatment |
| Loss of measures | Change from Baseline measures at 1 and 3 months | Decrease of measurements in perimeters (arm, waist, hip, thigh) |
Countries
Colombia
Outcome results
None listed